Alyeska Investment Group’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-399,652
Closed -$17.4M 869
2020
Q4
$17.4M Sell
399,652
-264,798
-40% -$9.05M 0.25% 125
2020
Q3
$18.8M Buy
664,450
+411,302
+162% +$13M 0.29% 110
2020
Q2
$9.19M Buy
+253,148
New +$7.13M 0.14% 212

Other funds holding ONEM

Alyeska Investment Group's ONEM Position: Q1 2021 in Review

Alyeska Investment Group sold out of 1Life Healthcare (ONEM) in Q1 2021, closing a stake of 399,652 shares — an estimated $17.4M sold.

Alyeska Investment Group first reported a position in ONEM in Q2 2020 and held it in 3 quarters. The position peaked at $18.8M in Q3 2020. 240 funds tracked by Wall St. Rank hold ONEM as of Q1 2021.

  • Alyeska Investment Group reported no remaining 1Life Healthcare position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 399,652 1Life Healthcare shares in Q1 2021, an estimated $17.4M.
  • Alyeska Investment Group first reported a position in 1Life Healthcare in Q2 2020 and held it in 3 quarters.
  • Alyeska Investment Group's 1Life Healthcare position peaked at $18.8M in Q3 2020.
  • 240 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.